Read more about the latest developments in MS research, treatments and specialist care, plus the latest updates on our work and the efforts of our amazing supporters
The MS Trust sends out a weekly news alert which includes the latest updates from the MS Trust, latest news, blogs and a news feed from MS in the Media.
Read our latest news
- MS-SMART trail unsuccessful
- People with progressive MS need early support
- PIP rules protest
- Is cannabis effective?
- The role of vitamin D unclear
- Pregabalin and gabapentin restrictions
- Statue by sculptor with MS unveiled
- More MS risk genes identified
- Gut enzyme potentially linked to MS
Back in September, a group of friends took on a gruelling canoe challenge in the Lake District, raising nearly £4,000 to support the MS Trust's vital work. Here, supporter Caroline Horton writes about the inspiration behind the challenge and the sense of achievement she felt after completing it.
Choosing a disease modifying drug (DMD) is an individual decision and it can be important to weigh up your options and think about what might work best for you. In this guest blog, Toni shares her experiences of choosing an MS treatment and explains what it was like to start on Plegridy.
The government has announced that from 1 November, medicinal cannabis can be prescribed by specialist doctors. In this blog, we look at what is meant by medicinal cannabis, how legislation is changing and what this is likely to mean for people with MS.
Choosing which disease modifying drug (DMD) to start is not always easy and sometimes you'll find that you don't get on with the drug you have chosen. In this guest blog, Jane shares her experience of making a decision about treatment.
A lot of people with MS will experience sexual problems at some point in their lives, but yet we often find it hard to speak up about sex and MS. We think this needs to change.
MS Trust supporter Kimberley Carey has designed a stunning pendant necklace to raise awareness and funds for the MS Trust.
When MS Trust supporter Rebecca Morrison signed up to our Alps Trek back in 2016, she could have never imagined just how life-affirming the experience would be. In this blog, she writes about her own journey with MS, what inspired her take on a challenge for the MS Trust, and why she’d encourage others to do the same.
In a new blog, a person with MS chronicles her journey taking part in a clinical trial for the drug bexarotene. Part 12, where Hellie ends up stopping the drug, but still remain on the trial.
- Smoking worsens MS
- Gilenya for younger people
- Social networks influence health
- Ten years of the Risk-sharing Scheme
As the final data from the MS Risk-Sharing scheme (RSS) is published in the BMJ, we reflect on how this pioneering scheme has changed the landscape for people living with MS.
The MS Trust has praised the pioneering work of the MS Risk Sharing Scheme (RSS) as the final results from the scheme are published in the Journal of Neurology, Neurosurgery and Psychiatry today (September 24).
In a new blog, a person with MS chronicles her journey taking part in a clinical trial for the drug bexarotene. Part 11, where Hellie wonders if she will still remain on the trial.
On 9 September, our team of 34 runners took on the iconic 13.1-mile route from Newcastle to South Shields.
Guest blogger Emily, also known as the wibbly dinosaur, writes about her life after being diagnosed with MS, and why she started blogging to help others who are new to MS.
In a new blog, a person with MS chronicles her journey taking part in a clinical trial for the drug bexarotene. Part 10, where Hellie starts taking the drug again, but then has to stop again.